Pharma Co. Amarin Beats Class Action Over Patent Issues
A New Jersey federal judge has tossed a proposed class action suit against pharmaceutical company Amarin and its top brass, alleging they misled shareholders about their products and the prospects of...To view the full article, register now.
Already a subscriber? Click here to view full article